Arbutus to Present at H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference
01. Oktober 2024 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its...
GeoVax to Participate in Upcoming Investor Conferences in September
03. September 2024 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today...
Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
20. Juni 2024 08:30 ET
|
Avenue Therapeutics
MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of...
Avenue Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference
05. September 2023 08:30 ET
|
Avenue Therapeutics
MIAMI, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of...
Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
06. September 2022 08:20 ET
|
Organovo, Inc.
SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), an early-stage biotechnology company that is focusing on building high fidelity, 3D tissues that recapitulate...
Arbutus to Participate in September Investor Conferences
06. September 2022 07:30 ET
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop...
Guardforce AI to Present at the H.C. Wainwright Global Investment Conference on May 24th
19. Mai 2022 07:00 ET
|
Guardforce AI Co., Ltd.
NEW YORK, NY, May 19, 2022 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited ("Guardforce AI" or the "Company") (NASDAQ: GFAI)(NASDAQ: GFAIW), an integrated security solutions provider, today announced...
ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference
16. Mai 2022 07:00 ET
|
ObsEva SA
GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that Company...
ObsEva to Present at the H.C. Wainwright Global Investment 2022 Conference
16. Mai 2022 01:00 ET
|
ObsEva SA
GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that Company...
F-star Therapeutics to Participate in Upcoming Investor Conferences
07. Januar 2022 08:00 ET
|
F-star Therapeutics, Inc.
CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Jan. 07, 2022 (GLOBE NEWSWIRE) -- F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing...